Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELDORADO: Effect of curcumin and piperine on tamoxifen pharmacokinetics
2016-004008-71Phase 4Completed
- Sponsor
- Erasmus MC Cancer Institute
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tamoxifen in breast cancer (3 arms), sponsored by Erasmus MC Cancer Institute. Primary endpoint: Tamoxifen/endoxifen AUC change with curcumin ± piperine. Started Nov 2016; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2016-004008-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004008-71.